首页|靶向循环肿瘤细胞治疗策略在抗肿瘤转移中的应用

靶向循环肿瘤细胞治疗策略在抗肿瘤转移中的应用

扫码查看
转移是肿瘤治疗的主要挑战,90%的肿瘤相关死亡病例与肿瘤转移有关.循环肿瘤细胞(circu-lating tumor cells,CTCs)是肿瘤转移形成的关键,与肿瘤转移的形成过程密切相关.因此,靶向CTCs的治疗策略成为目前抗肿瘤转移研究的热点.基于此,本文从CTCs的产生、CTCs的播散和CTCs的远端定植三个阶段综述了CTCs参与肿瘤转移的机制,并分别从调节肿瘤转移相关基因表达和抑制EMT过程抑制肿瘤细胞脱落产生CTCs、激活自身免疫细胞和仿生细胞膜或特异性分子修饰纳米制剂在血液循环捕获消除CTCs、抑制CTCs黏附并穿过血管内皮细胞和破坏PMN处适宜肿瘤细胞生长的微环境等方面总结了控制肿瘤转移的研究进展,以期为肿瘤转移预防和治疗提供新的思路.
Application of circulating tumor cell-targeting therapy strategies in anti-tumor metastasis
Metastasis is the major challenge in cancer treatment and is responsible for 90%of cancer-related deaths.Circulating tumor cells(CTCs)are the key to the formation of tumor metastasis,which is closely related to the formation process of tumor metastasis.Therefore,the CTCs-targeting therapeutic strategies have become a hot spot in the research of anti-tumor metastasis.Based on this,this paper reviews the mechanism of CTCs involved in tumor metastasis from three stages:the generation of CTCs,the dissemination of CTCs,and the distal colonization of CTCs.In addition,the research progress of controlling tumor metastasis is summarized from the following aspects:regulating tumor metastasis-related gene expression and inhibiting EMT process to prevent tumor cells from shedding to produce CTCs,capturing and eliminating CTCs in the circulation through activation of autoimmune cells and biomimetic cell membranes or specific molecular-modified nanoparticles,inhibiting the adhesion and passage of CTCs to endothelial cells and disrupt the microenvironment of PMN for tumor cell growth.It provides new ideas for the prevention and treatment of tumor metastasis.

circulating tumor cellstumor metastasis mechanismanti-metastatic therapynano-carrierpre-metastatic niche

夏振兴、牟伟伟、刘永军、张娜

展开 >

山东大学药学院,天然产物化学生物学教育部重点实验室,济南 250012

循环肿瘤细胞 肿瘤转移机制 抗转移治疗 纳米载体 转移前微环境

国家自然科学基金面上项目

82173757

2023

生命的化学
中国生物化学与分子生物学会

生命的化学

CSTPCD
影响因子:0.404
ISSN:1000-1336
年,卷(期):2023.43(1)
  • 48